Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
Clinical trial NCT03623854 · COMPLETED
Trial details
- NCT number
- NCT03623854
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-03
- Primary completion
- 2023-09-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.